Primary Hyperoxaluria Oxalate Burden Calculator

Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response

Each component has a specific meaning:

  • 24-hour urinary oxalate — The 24-hour urinary oxalate recorded for the scenario being assessed.
  • Plasma oxalate — The plasma oxalate recorded for the scenario being assessed.
  • GFR — The gfr recorded for the scenario being assessed.
  • Estimates crystallization risk — The estimates crystallization risk recorded for the scenario being assessed.
  • Lumasiran/oxalate lowering therapy response — The lumasiran/oxalate lowering therapy response recorded for the scenario being assessed.

Note: Interpret the ph oxalate burden result against the thresholds and context described above.

How to Use

Enter the 24-hour urinary oxalate, plasma oxalate, GFR, estimates crystallization risk, lumasiran/oxalate lowering therapy response for the scenario you are assessing. Calculates systemic oxalate burden in primary hyperoxaluria types 1-3 using 24-hour urinary oxalate, plasma oxalate, GFR, and estimates crystallization risk and lumasiran/oxalate lowering therapy response. Use the ph oxalate burden result to inform your calculation.

Frequently Asked Questions